Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as

I Tichmann1, H Preidel, D Grunert

  • 1Arztpraxis München, Germany.

Vaccine
|April 20, 2005
PubMed

Insights

Infanrix hexa demonstrated superior immunogenicity for the hepatitis B vaccine component compared to Hexavac in infants. Antibody responses to diphtheria and polio were also higher with Infanrix hexa, with similar safety profiles.

Area of Science:

  • Pediatric Vaccinology
  • Immunology
  • Public Health

Background:

  • Infant vaccination schedules are critical for establishing early immunity against serious diseases.
  • Comparative studies are essential to evaluate the efficacy and safety of different vaccine formulations.

Purpose of the Study:

  • To compare the immunogenicity and safety of Infanrix hexa versus Hexavac vaccines in infants.
  • To assess antibody responses to hepatitis B, diphtheria, polio, tetanus, Hib, and pertussis components.

Main Methods:

  • A randomized trial involving 459 infants receiving either Infanrix hexa or Hexavac at 2, 4, and 6 months.
  • Immunogenicity assessed via seroprotection rates and Geometric Mean Concentrations (GMCs) for hepatitis B.
  • Antibody levels measured for diphtheria, polio, tetanus, Hib, and pertussis components.

Main Results:

  • Infanrix hexa showed statistically significantly higher hepatitis B seroprotection (98.6% vs 94.7%) and GMCs (905.6 vs 226.4).
  • Significantly higher antibody levels against diphtheria and polio were observed with Infanrix hexa (p < 0.0001).
  • Comparable immune responses were noted for tetanus, Hib, and pertussis components; low adverse event rates in both groups.

Conclusions:

  • Infanrix hexa offers superior immunogenicity for its hepatitis B component compared to Hexavac in infants.
  • Infanrix hexa also induces higher antibody levels for diphtheria and polio antigens.
  • Both vaccines exhibited favorable safety profiles, with low incidences of adverse events.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...